Article
A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease.
Journal of the American Society of Nephrology : JASN - 1 Jun 2017
Tchernitchko Dimitri, Tavernier Quentin, Lamoril Jérôme, Schmitt Caroline, Talbi Neila, Lyoumi Said, Robreau Anne-Marie, Karim Zoubida, Gouya Laurent, Thervet Eric, Karras Alexandre, Puy Hervé, Pallet Nicolas
Abstract excerpt
CKD occurs in most patients with acute intermittent porphyria (AIP). During AIP, δ-aminolevulinic acid (ALA) accumulates and promotes tubular cell death and tubulointerstitial damage. The human peptide transporter 2 (PEPT2) expressed by proximal tubular cells mediates the reabsorption of ALA, and variants of PEPT2 have different affinities for ALA. We tested the hypothesis that PEPT2 genotypes affect the severity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
